Ramelteon Tablet — FDA Drug Shortage

To Be Discontinued — Takeda Pharmaceuticals USA Inc.

The FDA lists a drug shortage record for Ramelteon Tablet (tablet) from Takeda Pharmaceuticals USA Inc. with status To Be Discontinued. The shortage was first posted on 03/19/2026.

Shortage Details

Status
To Be Discontinued
Company
Takeda Pharmaceuticals USA Inc.
Package NDC
64764-805-30
Dosage Form
Tablet
Presentation
Rozerem, Tablet, 8 mg (NDC 64764-805-30)
Initial Posting
03/19/2026
Revised Date